Education
About Us
Working with TipRanks
Follow Us
Andrew Schutte Insider Profile
4 Followers
Andrew Schutte, Director, Ten Percent Owner at RepliCel Life Sciences, holds 19.37M shares in RepliCel Life Sciences (Ticker: REPCF).
Andrew Schutte RepliCel Life Sciences (REPCF)Director, Ten Percent Owner
RepliCel Life Sciences (REPCF)
Director, Ten Percent Owner
Ranked #85,770 out of 102,596 Corporate Insiders
Profitable Transactions
3 out of 9 Profitable Transactions
Average Return
-18.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Andrew Schutte's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Andrew Schutte holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 28, 2022 - May 28, 2023
Return:+73.00%
The most profitable trade made by Andrew Schutte
Andrew Schutte's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Schutte's performance on stock
You May Also Like
Andrew Schutte insider profile FAQ
What is the percentage of profitable transactions made by Andrew Schutte?
The percentage of profitable transactions made by Andrew Schutte is 33%.
What is the average return per transaction made by Andrew Schutte?
The average return per transaction made by Andrew Schutte is -18.40%.
What stocks does Andrew Schutte hold?
Andrew Schutte holds: REPCF stocks.
What was Andrew Schutte’s latest transaction?
Andrew Schutte latest transaction was an Uninformative Buy of ―.
What was Andrew Schutte's most profitable transaction?
Andrew Schutte’s most profitable transaction was an Informative Buy of REPCF stock on May 28, 2022. The return on the trade was 73.00%.
What is Andrew Schutte's role in RepliCel Life Sciences?
Andrew Schutte's role in RepliCel Life Sciences is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.